AVITA Medical Announces Listing on Nasdaq – Trading of American Depository Shares to begin under the ticker symbol “RCEL” on October 1st

Link to Full Article Valencia, Calif., USA, and Melbourne, Australia, 30 September, 2019 — AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced that its American Depositary Shares (“ADS”) have been approved to list on the Nasdaq Capital Market […]

New Data Published in Aesthetic Plastic Surgery Explores the Use of the RECELL System in Combination with Dermabrasion to Treat Acne Scars

Link to Full Article Recent journal publications investigate the potential use of the RECELL System to treat multiple dermatological conditions Valencia, Calif., USA, and Melbourne, Australia, 19 September 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company focused on the development and commercialization of innovative therapies leveraging the healing properties of a […]

AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval of Pivotal Study Evaluating RECELL System for Soft Tissue Reconstruction

Link to Full Article First RECELL System clinical trial in the U.S. focused on acute soft tissue injuries, defects, and reconstruction; study expected to commence within next 6 months Valencia, Calif., USA, and Melbourne, Australia, 17 September 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company focused on the development and commercialization […]

AVITA Medical Added to the S&P/ASX 300 Index

Link to Full Article Valencia, Calif., USA, and Melbourne, Australia, 6 September 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, acknowledges that the company will be added to the S&P/ASX 300 index, effective upon market open on 23 September 2019. “We are pleased to be included in the S&P/ASX 300 […]

AVITA Medical Reports Fourth Quarter Fiscal 2019 Financial Results and Company Update

Link to Full Article • Total revenue of A$17.0 million for fiscal year 2019 (FY19), an increase of 50% year-over-year • U.S. product sales of A$6.2 million for FY19 • U.S. product sales of A$2.9 million for fourth quarter, an increase of 32% compared to FY third quarter sales Valencia, Calif., USA, and Melbourne, Australia, […]

RECELL® System Feasibility Study Results for Treatment of Diabetic Foot Ulcers Presented at 11th Annual Congress of the Japanese Society of Limb Salvage & Podiatric Medicine

Link to Full Article Innovative regenerative technology using patients’ own skin cells significantly reduced size of wounds caused by diabetic foot ulcers in all patients Valencia, Calif., USA, and Melbourne, Australia, 01 July 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY) a global regenerative medicine company, announced today favorable results from an open-label feasibility study […]

AVITA Medical Announces RECELL® System Preliminary Data Focused on Vitiligo and Facial Acne Scars at the 24th Annual World Congress of Dermatology

Link to Full Article Abstracts Showcase Research on Potential Use of RECELL® System in Regenerative Dermatology Valencia, Calif., USA, and Melbourne, Australia, June 12, 2019 —AVITA Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announces new preliminary RECELL® Autologous Cell […]

Health Economic Model Published in Advances in Therapy Demonstrates Reduced Cost and Decreased Hospital Stay with the RECELL® System

Link to Full Article Real world experience found that the RECELL System could save one US Burn Center up to USD $28MM annually Valencia, Calif., USA, and Melbourne, Australia, 16 May 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY) announced today that the health economic model of the U.S. burn care pathway, developed in collaboration […]

AVITA Medical Appoints Interim CFO

Link to Full Article Valencia, Calif., USA, and Melbourne, Australia, 15 May 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company,  announced today that Dale A. Sander is resigning as Chief Financial Officer (CFO) to spend more time with his family on the east coast, effective immediately. Tim Rooney, AVITA’s Chief […]